Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshitake Kanbe is active.

Publication


Featured researches published by Yoshitake Kanbe.


Archive | 1991

Novel benzopyran derivatives

Jae Chon Jo; Sung Dae Park; Hyun Suk Lim; Ju Su Kim; Sungjin Kim; Kazumi Morikawa; Yoshitake Kanbe; Masahiro Nishimoto; Myunghwa Kim


Bioorganic & Medicinal Chemistry Letters | 2006

Discovery of thiochroman derivatives bearing a carboxy-containing side chain as orally active pure antiestrogens

Yoshitake Kanbe; Myung Hwa Kim; Masahiro Nishimoto; Yoshihito Ohtake; Toshiaki Tsunenari; Kenji Taniguchi; Iwao Ohizumi; Shin ichi Kaiho; Yoshiaki Nabuchi; Setsu Kawata; Kazumi Morikawa; Jae Chon Jo; Hee An Kwon; Hyun Suk Lim; Hak Yeop Kim


Anticancer Research | 2010

Thiochroman derivative CH4986399, a new nonsteroidal estrogen receptor down-regulator, is effective in breast cancer models.

Takaaki Yoneya; Kenji Taniguchi; Ryo Nakamura; Toshiaki Tsunenari; Iwao Ohizumi; Yoshitake Kanbe; Kazumi Morikawa; Shin-ichi Kaiho; Hisafumi Yamada-Okabe


Archive | 1999

Novel benzopyran or thiobenzopyran derivatives

Jae Chon Jo; Hyun Suk Lim; JongMin Kim; Ju Su Kim; Kazumi Morikawa; Yoshitake Kanbe; Myung Hwa Kim; Masahiro Nishimoto


Archive | 2003

Benzopyran or thiobenzopyran derivatives

Jae Chon Jo; Hyun Suk Lim; Jong Min Kim; Ju Su Kim; Kazumi Morikawa; Yoshitake Kanbe; Myung Hwa Kim; Masahiro Nishimoto


Bioorganic & Medicinal Chemistry | 2006

Discovery of thiochroman and chroman derivatives as pure antiestrogens and their structure–activity relationship

Yoshitake Kanbe; Myung Hwa Kim; Masahiro Nishimoto; Yoshihito Ohtake; Nobuaki Kato; Toshiaki Tsunenari; Kenji Taniguchi; Iwao Ohizumi; Shin ichi Kaiho; Kazumi Morikawa; Jae Chon Jo; Hyun Suk Lim; Hak Yeop Kim


Bioorganic & Medicinal Chemistry Letters | 2006

Newly discovered orally active pure antiestrogens

Yoshitake Kanbe; Myung Hwa Kim; Masahiro Nishimoto; Yoshihito Ohtake; Takaaki Yoneya; Iwao Ohizumi; Toshiaki Tsunenari; Kenji Taniguchi; Shin ichi Kaiho; Yoshiaki Nabuchi; Hiroshi Araya; Setsu Kawata; Kazumi Morikawa; Jae Chon Jo; Hee An Kwon; Hyun Suk Lim; Hak Yeop Kim


Archive | 2000

Compounds with hydroxycarbonyl-halogenoalkyl side chain

Jaechon Jo; Heean Kwon; Hyun Suk Lim; Jaeyoung Choi; Kazumi Morikawa; Yoshitake Kanbe; Masahiro Nishimoto; Myunghwa Kim; Yoshikazu Nishimura


Oncology Reports | 2009

Effects of CH4893237, a new orally active estrogen receptor downregulator, on breast cancer xenograft models with low serum estrogen levels

Takaaki Yoneya; Toshiaki Tsunenari; Kenji Taniguchi; Yoshitake Kanbe; Kazumi Morikawa; Hisafumi Yamada-Okabe; Yeon-Ho Lee; Mee-Hyun Lee; Lae-Sung Kwon


Archive | 2000

Optically active chroman and thiochroman derivatives

Sungdae Park; Heean Kwon; HongKi Kim; Pil-Su Ho; Kazumi Morikawa; Yoshitake Kanbe; Masahiro Nishimoto; Myunghwa Kim

Collaboration


Dive into the Yoshitake Kanbe's collaboration.

Top Co-Authors

Avatar

Kazumi Morikawa

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Myunghwa Kim

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Hyun Suk Lim

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Jaechon Jo

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Kenji Taniguchi

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jaeyoung Choi

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Myung Hwa Kim

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge